| ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order | 
|---|---|---|---|---|---|---|
| 134897-100MG | 
                     | 
                1258327-07-9 | 
                     (11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                100MG | C33H19F12O4P | |
| 134897-25MG | 
                     | 
                1258327-07-9 | 
                     (11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                25MG | C33H19F12O4P | |
| 134896-1G | 
                     | 
                1297613-76-3 | 
                     (11aR)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥95%,99%e.e.  | 
                1G | C33H19F12O4P | |
| 134896-100MG | 
                     | 
                1297613-76-3 | 
                     (11aR)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥95%,99%e.e.  | 
                100MG | C33H19F12O4P | |
| 134896-25MG | 
                     | 
                1297613-76-3 | 
                     (11aR)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥95%,99%e.e.  | 
                25MG | C33H19F12O4P | |
| 134851-1G | 
                     | 
                1258327-04-6 | 
                     (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                1G | C29H23O4P | |
| 134851-100MG | 
                     | 
                1258327-04-6 | 
                     (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                100MG | C29H23O4P | |
| 134851-25MG | 
                     | 
                1258327-04-6 | 
                     (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                25MG | C29H23O4P | |
| 134852-1G | 
                     | 
                1297613-72-9 | 
                     (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                1G | C29H23O4P | |
| 134852-100MG | 
                     | 
                1297613-72-9 | 
                     (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                100MG | C29H23O4P | |
| 134852-25MG | 
                     | 
                1297613-72-9 | 
                     (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                25MG | C29H23O4P | |
| 135047-1G | 
                     | 
                1258327-03-5 | 
                     (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                1G | C17H15O4P | |
| 135047-100MG | 
                     | 
                1258327-03-5 | 
                     (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                100MG | C17H15O4P | |
| 135047-25MG | 
                     | 
                1258327-03-5 | 
                     (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                25MG | C17H15O4P | |
| 135046-1G | 
                     | 
                1352810-35-5 | 
                     (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                1G | C17H15O4P | |
| 135046-100MG | 
                     | 
                1352810-35-5 | 
                     (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                100MG | C17H15O4P | |
| 135046-25MG | 
                     | 
                1352810-35-5 | 
                     (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                25MG | C17H15O4P | |
| 137672-1G | 
                     | 
                NA | 
                     (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-1-pyrenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin ≥98%,99%e.e.  | 
                1G | C52H37O4P | |
| 137672-100MG | 
                     | 
                NA | 
                     (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-1-pyrenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin ≥98%,99%e.e.  | 
                100MG | C52H37O4P | |
| 137672-25MG | 
                     | 
                NA | 
                     (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-1-pyrenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin ≥98%,99%e.e.  | 
                25MG | C52H37O4P | |